Hugh Alfred Burgoon - Hamilton NJ, US Nicole Cathleen Goodwin - Pennington NJ, US Bryce Alden Harrison - Hamilton NJ, US Jason Patrick Healy - Flemington NJ, US Ying Liu - Lawrenceville NJ, US Ross Mabon - Princeton NJ, US Brett Marinelli - Hamilton NJ, US David Brent Rawlins - Morrisville PA, US Dennis Stewart Rice - The Woodlands TX, US Norris Andrew Whitlock - The Woodlands TX, US
Assignee:
Lexicon Pharmaceuticals, Inc. - The Woodlands TX
International Classification:
A01N 43/90 A61K 31/519 C07D 487/00
US Classification:
5142651, 544280
Abstract:
Inhibitors of LIM kinase 2 are disclosed, along with pharmaceutical compositions comprising them and methods of their use. Particular compounds are of the formula:.
Csl Behring
Senior Clinical Scientist
Akros Pharma Inc. Nov 2016 - Nov 2018
Clinical Research Scientist
The Children's Hospital of Philadelphia Mar 2014 - Nov 2016
Clinical Pharmacology Fellow
Thomas Jefferson University Hospitals Mar 2014 - Nov 2016
Clinical Pharmacology Fellow
West Virginia University Jul 2008 - Mar 2014
Graduate Research Assistant
Education:
Thomas Jefferson University 2014 - 2016
Thomas Jefferson University Hospitals 2014 - 2015
West Virginia University 2008 - 2014
Doctorates, Doctor of Philosophy, Philosophy
College of Dupage 2006 - 2007
University of Iowa 2000 - 2004
Bachelors, Bachelor of Science, Chemistry
Skills:
Drug Discovery Drug Development Grant Writing Clinical Development Biologics Rare Diseases Clinical Trials Regulatory Submissions Medical Writing Clinical Research Fda Clinical Operations Clinical Pharmacology Small Molecules Ema Translational Research Pk/Pd Cell Culture Animal Models Molecular and Cellular Biology Biochemistry Graphpad Prism Neuropharmacology Purification Organic Chemistry Spectroscopy Characterization Uv/Vis Organic Synthesis Microsoft Office
Jason Healy (1989-1993), Noel Gordon (1978-1982), Janine Solujich (2002-2006), Ellen Jardine (1982-1986), Paul Maselli (1974-1978), Roberto Munoz (1976-1980)
We know there is some fraud in the U.S. system, but it has always been in the margins, said Jason Healy a senior research scholar at Columbia University and a former White House Director of Critical Infrastructure Protection.The threat of Russia trying to influence this election is an absolute concern, said Jason Healy, who has been studying election policies and the state and U.S. government approach to protecting their systems. Healy would like to see elections treated as if theyre a part of critical infrastructure
Date: Sep 26, 2016
Category: U.S.
Source: Google
CDC's 2015 'Tips' Campaign Includes Anti E-Cig Spot
ll discourage peoplefrom giving up smoking or encourage them to do their own research into e-cigarettes, writes the WSJs Mickle. The anti-side has been spewing crap like this constantly, butwe continue to grow, Jason Healy, president and founder of Lorillards Blu tells Mickle. People know th
Date: Mar 26, 2015
Category: Health
Source: Google
US Ad Campaign to Challenge Value of E-Cigarettes in Quitting Smoking
The anti-side has been spewing crap like this constantly, but we continue to grow, said Jason Healy, president and founder of Blu, a large e-cigarette brand owned by Lorillard Inc., maker of Newport smokes. People know the truth about e-cigarettes, he added.
Rockefeller was somewhat more hostile to Jason Healy of Blu and Craig Weiss of Njoy, CEOs of two of the leading companies in the e-cigarette market. Making money is a wonderful thing, but children and teens should not be guinea pigs as we await more conclusive research. Why would you do that? You w
Date: Jun 19, 2014
Category: Health
Source: Google
E-cigarettes could sweeten potential Reynolds-Lorillard deal
game, though it only introduced its MarkTen brand in August 2013 in Indiana. It plans a nationwide rollout next month. Lorillard bought blu two years ago from founder Jason Healy and his investors for $135 million. A year later, it paid $49 million for SKYCIG, now the leading e-cigarette in Britain.
It seems to be a responsible approach and shows the FDAs commitment to look at particular e-cigarettes in a science-based way rather than just conjecture, said Jason Healy, president of Blu e-cigs, which is owned by the tobacco company Lorillard Inc. and is the largest player in the market. Blu
responsible approach ... and shows the FDA's commitment to look at particular e-cigarettes in a science-based way rather than just conjecture," said Jason Healy, president of Blue-cigs, which is owned by Lorillard Inc. and holds more than 45 percent of the market. "Obviously we've got a long way to go.
"There's going to be some pain," says Jason Healy, president of blu eCigs, the leading e-cigarette company in the U.S. market, citing the costs. But he says "we're in the public health space" and need to produce responsible products.